BMY.RT

Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT

Overview Fund Activity
Delisted

BMY.RT was delisted on the 31st of December, 2020.

Back to rankings

4 hedge funds and large institutions have $3.59M invested in Bristol-Myers Squibb Company Contingent Value Rights in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
1
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
JCI
1
Jet Capital Investors
New York
$3.59M

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
JCI
1
Jet Capital Investors
New York
$3.59M 2,661,301 +2,661,301 New
BCM
2
Beddow Capital Management
Wyoming
$0 215,300 -354,989 -62%
MAM
3
Meeder Asset Management
Ohio
– – -5 Closed
PDN
4
Pensionfund DSM Netherlands
Netherlands
$0 33,000 – –
PS
5
Pensionfund Sabic
Netherlands
$0 23,000 – –